Alfa Scientific Designs, Inc. Product Pipeline Analysis

SUMMARY

Alfa Scientific Designs, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Alfa Scientific Designs, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Company Overview 7
2.1 Key Information 7
2.2 Industry Outlook -- In Vitro Diagnostics 7
3 Major Products and Services 8
3.1 Overview 8
4 Competitors 9
5 Locations And Subsidiaries 10
5.1 Head Office 10
6 Alfa Scientific Designs, Inc. Pipeline Products 11
6.1 Alfa Scientific Designs, Inc. Product Pipeline Analysis 11
6.1.1 Alfa Scientific Designs, Inc. Pipeline Products By Equipment Type 11
6.1.2 Alfa Scientific Designs, Inc. Pipeline Products By Development Stage 12
6.1.3 Alfa Scientific Designs, Inc. Pipeline Products By Therapy Area 13
6.2 Instant-View Pregnancy Combo II Test 13
6.2.1 Product Description 13
6.2.2 Product Status 13
6.3 Instant-View HBsAg Serum Test 14
6.3.1 Product Description 14
6.3.2 Product Status 14
6.4 Instant-View HBsAg Whole Blood Test 14
6.4.1 Product Description 14
6.4.2 Product Status 15
6.5 Instant-View Hepatitis C (HCV) Serum Test 15
6.5.1 Product Description 15
6.5.2 Product Status 15
6.6 HCV Whole Blood Cassette Test 16
6.6.1 Product Description 16
6.6.2 Product Status 16
6.7 Instant-View PSA Semi-Quantitative Serum Cassette Test 16
6.7.1 Product Description 16
6.7.2 Product Status 17
6.8 Instant-View PSA semi-quantitative whole blood cassette 17
6.8.1 Product Description 17
6.8.2 Product Status 18
7 Appendix 19
7.1 Methodology 19
7.1.1 Coverage 19
7.1.2 Secondary Research 20
7.1.3 Primary Research 20
7.1.4 Expert Panel Validation 21
7.2 Contact Us 21
7.3 About Global Markets Direct 21
7.4 Disclaimer 21

1.1 List of Tables
Table 1: Alfa Scientific Designs, Inc.,Key Facts 7
Table 2: Alfa Scientific Designs, Inc. Pipeline Products by Equipment Type 11
Table 3: Alfa Scientific Designs, Inc. Pipeline Products By Development Stage 12
Table 4: Alfa Scientific Designs, Inc. Pipeline Products By Therapy Area 13

1.2 List of Figures
Figure 1: Alfa Scientific Designs, Inc. Pipeline Products By Development Stage 12
Figure 2: Global Markets Direct Methodology 19